ArticleThyroid : official journal of the American Thyroid Association2021

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma.

Christine Dierks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.